Biocon to sell 70% in Axicorp

Kiran Majumdar Shaw, MD of Biocon announces divestment of 70% in the company's German arm - Axicorp GmbH following its global alliance with Pfizer for commercialisation of biosimilar insulin and insulin analogs.

Related Videos